Search research articles
Contact Us
Filters
Showing results (481-490 of 657) with videos related to
Page
of 66
Sort By:
Advances in Radiation Oncology
|
August 6, 2024
Impact of Clinical Factors on <sup>18</sup>F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study
Benjamin H Lowentritt, Ashesh B Jani, Brian T Helfand, et al.
Sexual Medicine
|
January 11, 2021
Examining Online Traffic Patterns to Popular Direct-To-Consumer Websites for Evaluation and Treatment of Erectile Dysfunction
Joel J Wackerbarth, Richard J Fantus, Annie Darves-Bornoz, et al.
Aging Cell
|
October 22, 2010
Chromatin remodeling in the aging genome of Drosophila
Jason G Wood, Sara Hillenmeyer, Charles Lawrence, et al.
Journal of Clinical Epidemiology
|
January 7, 2011
GRADE guidelines: 3. Rating the quality of evidence
Howard Balshem, Mark Helfand, Holger J Schünemann, et al.
Blood
|
July 15, 1995
Functional interleukin-2 receptors are expressed on natural killer-like leukemic cells from a dog with cutaneous lymphoma
S C Helfand, J F Modiano, P F Moore, et al.
Journal of Endocrinological Investigation
|
February 22, 2024
Novel reference range values for serum testosterone: a cross-sectional study of 200,000 males
Richard J Fantus, Daniel R Greenberg, Cecilia Chang, et al.
JAMA Network Open
|
December 28, 2019
Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis
Rong Na, Craig Labbate, Hongjie Yu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 10, 2023
Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes
Liana K Billings, Zhuqing Shi, Jun Wei, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 19, 2012
Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group
Eric Faulkner, Lieven Annemans, Lou Garrison, et al.
Clinical and Translational Science
|
June 29, 2011
A CTSA agenda to advance methods for comparative effectiveness research
Mark Helfand, Sean Tunis, Evelyn P Whitlock, et al.
Page
of 66
Search research articles
Search
Showing results (481-490 of 657) with videos related to
Sort By:
Page
of 66
Advances in Radiation Oncology
|
August 6, 2024
Impact of Clinical Factors on <sup>18</sup>F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study
Benjamin H Lowentritt, Ashesh B Jani, Brian T Helfand, et al.
Sexual Medicine
|
January 11, 2021
Examining Online Traffic Patterns to Popular Direct-To-Consumer Websites for Evaluation and Treatment of Erectile Dysfunction
Joel J Wackerbarth, Richard J Fantus, Annie Darves-Bornoz, et al.
Aging Cell
|
October 22, 2010
Chromatin remodeling in the aging genome of Drosophila
Jason G Wood, Sara Hillenmeyer, Charles Lawrence, et al.
Journal of Clinical Epidemiology
|
January 7, 2011
GRADE guidelines: 3. Rating the quality of evidence
Howard Balshem, Mark Helfand, Holger J Schünemann, et al.
Blood
|
July 15, 1995
Functional interleukin-2 receptors are expressed on natural killer-like leukemic cells from a dog with cutaneous lymphoma
S C Helfand, J F Modiano, P F Moore, et al.
Journal of Endocrinological Investigation
|
February 22, 2024
Novel reference range values for serum testosterone: a cross-sectional study of 200,000 males
Richard J Fantus, Daniel R Greenberg, Cecilia Chang, et al.
JAMA Network Open
|
December 28, 2019
Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis
Rong Na, Craig Labbate, Hongjie Yu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 10, 2023
Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes
Liana K Billings, Zhuqing Shi, Jun Wei, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 19, 2012
Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group
Eric Faulkner, Lieven Annemans, Lou Garrison, et al.
Clinical and Translational Science
|
June 29, 2011
A CTSA agenda to advance methods for comparative effectiveness research
Mark Helfand, Sean Tunis, Evelyn P Whitlock, et al.
Page
of 66